Health-system specialty pharmacy role and outcomes: a review of current literature

AD Zuckerman, K Whelchel, M Kozlicki… - American Journal of …, 2022 - academic.oup.com
Purpose Specialty medications can have life-altering outcomes for patients with complex
diseases. However, their benefit relies on appropriate treatment selection, patients' ability to …

Proportion of days covered as a measure of medication adherence

J Loucks, AD Zuckerman, A Berni… - American Journal of …, 2022 - academic.oup.com
Medication adherence plays a significant role in specialty pharmacy practice and depends
on numerous factors. 1 The 2 most common adherence metrics using prescription claims are …

Cystic fibrosis screening, evaluation, and management of hepatobiliary disease consensus recommendations

ZM Sellers, DN Assis, SM Paranjape, M Sathe… - Hepatology, 2024 - journals.lww.com
Cystic fibrosis (CF) may cause a spectrum of hepatobiliary complications, including portal
hypertension, multilobular cirrhosis, and liver failure. Current guidelines on the detection …

2022 ASHP Survey of Health-System Specialty Pharmacy Practice: Clinical Services

AD Zuckerman, J Mourani, A Smith… - American Journal of …, 2023 - academic.oup.com
Purpose Results of the first ASHP national survey of clinical services provided by health-
system specialty pharmacies (HSSPs) are presented. Methods A survey questionnaire was …

Understanding the expanding role of pharmacy services in outpatient cystic fibrosis care

JT Zobell, J Moss, S Heuser, L Roe… - Pediatric …, 2021 - Wiley Online Library
Cystic fibrosis (CF) patients utilize an average of 10 (±5) medications per day. Given the
complexity of the medication regimen, the CF Foundation (CFF) recommends pharmacists …

Impact of a pharmacy technician and pharmacist on time to inhaled tobramycin therapy in a pediatric cystic fibrosis clinic

TE Burrus, H Vogt, RS Pettit - Pediatric Pulmonology, 2021 - Wiley Online Library
Background Cystic fibrosis (CF) patients who grow Pseudomonas aeruginosa on respiratory
culture are commonly prescribed inhaled tobramycin (TIS) to eradicate the organism. The …

Impact of pharmacy technicians as part of an integrated health‐system pharmacy team on improvement of medication access in the care of cystic fibrosis patients

JT Zobell, J Moss, SM Heuser… - Pediatric Pulmonology, 2020 - Wiley Online Library
Background Cystic fibrosis (CF) is a genetic disease requiring patients to take multiple
medications per day. Multiple barriers exist affecting access and adherence. Studies have …

Impact of pharmacy services on time to elexacaftor-tezacaftor-ivacaftor initiation

L Roder, M Simonsen, L Fitzpatrick, J He… - Journal of Managed Care …, 2022 - jmcp.org
BACKGROUND: The approval of elexacaftor-tezacaftor-ivacaftor (ELX/TEZ/IVA) expanded
highly effective cystic fibrosis transmembrane receptor modulator therapy to approximately …

The indispensable role of pharmacy services and medication therapy management in cystic fibrosis

JJ Grant, EJ McDade, JT Zobell… - Pediatric …, 2022 - Wiley Online Library
Care for people with cystic fibrosis (PWCF) is highly complex and requires a
multidisciplinary approach where the pharmacist plays a vital role. The purpose of this …

Analyzing the costs of developing and operating an integrated health-system specialty pharmacy: the case of a centralized insurance navigation process for specialty …

MH Rim, KC Thomas, SA Barrus… - American Journal of …, 2021 - academic.oup.com
Purpose Direct and indirect costs related to the growth of specialty pharmacy services and
the insurance navigation process for specialty clinic patients are discussed, and …